Hwu, Wen-Jen <br/><br/>
Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study.  [electronic resource] 

 -  Cancer  Jun 2005 
 - 2590-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/cncr.21081  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Brain Neoplasms--drug therapy<br/>Dacarbazine--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Neoplasm Staging<br/>Skin Neoplasms--drug therapy<br/>Survival Rate<br/>Temozolomide<br/>Thalidomide--administration & dosage<br/>Treatment Outcome